Anticoagulation protocol and early prosthetic valve thrombosis

Indian Heart Journal

Volumn 56, Issue 3, 2004, Pages 225-228

  Talwar, Sachin ^a   Kapoor, Chandra Kanta ^a   Velayoudam, Devagourou ^a   Kumar, Arkalgud Sampath ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anticoagulants; Prosthetic valve thrombosis; Valvular heart disease

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ENOXAPARIN;

ADOLESCENT; ADULT; ANTICOAGULATION; AORTA VALVE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORBIDITY; MORTALITY; PROSTHETIC VALVE THROMBOSIS; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; ANTICOAGULANTS; ENOXAPARIN; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; MEDICAL FUTILITY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TREATMENT OUTCOME;

EID: 6044257471     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Edmunds LH Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987; 44: 430-445
2. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641
3. Miller DC, Oyer PE, Stinson EB, Reitz BA, Jamieson SW, Baumgartner WA, et al. Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards model 6120 mitral valve prosthesis. J Thorac Cardiovasc Surg 1983; 85: 1-20
4. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698
5. Harenberg J, Schwarz F, Dietz R, Leber G, Zimmermann R, Kubler W. Anticoagulation with low molecular-weight heparin in patients with prosthetic heart valve replacement. Z Kardiol 1987; 76: 284-288
6. Stein PD, Dalen JE, Goldman S, Theroux P. Antithrombotic therapy in patients with saphenous vein and internal mammary bypass grafts. Chest 1998; 114: 658S-665S
7. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1996; 112: 708-711
8. Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541
9. Steele P, Rainwater J, Vogel R. Platelet suppressant therapy in patients with prosthetic heart valves. Circulation 1979; 60: 910-913
10. Kohanna FH, Salzman EW. Thromboembolic complications of cardiac and vascular prostheses. In: Sabiston DC Jr, Spencer FC (eds). Gibbon's Surgery of the Chest. Philadelphia: Saunders, 1983, pp1267
11. Laplace G, Lafitte S, Labeque JN, Perron JM, Baudet E, Deville C, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004; 43: 1283-1290
12. Deykin D. Anticoagulant therapy in hemostasis and thrombosis. In: Column RW, Hirsh J, Marder VJ, Salzman EW (eds). Hemostasis and Thrombosis. Philadelphia: Lippincott, 1982, pp 1000-1012
13. Harenberg J, Leber G, Dempfle CE, Heene DL, Zimmermann R, Kubler W. Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulation. Nouv Rev Fr Hematol 1989; 31: 363-369